Financial Gravity Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4
| Closed | -$4.11K | – | 2285 |
|
|
2024
Q1 | $4.11K | Hold |
4
| – | – | ﹤0.01% | 905 |
|
|
2023
Q4 | $5.71K | Buy |
4
+2
| +100% | +$2.86K | ﹤0.01% | 860 |
|
|
2023
Q3 | $2.68K | Sell |
2
-717
| -100% | -$961K | ﹤0.01% | 683 |
|
|
2023
Q2 | $1.96K | Sell |
719
-103
| -13% | -$281 | 0.01% | 643 |
|
|
2023
Q1 | $3.04K | Buy |
822
+101
| +14% | +$374 | 0.09% | 239 |
|
|
2022
Q4 | $2.42K | Sell |
721
-7,547
| -91% | -$25.3K | 0.01% | 510 |
|
|
2022
Q3 | $2.55K | Sell |
8,268
-9,462
| -53% | -$2.92K | 0.09% | 237 |
|
|
2022
Q2 | $4.36K | Sell |
17,730
-3,210
| -15% | -$790 | 0.14% | 157 |
|
|
2022
Q1 | $5.47K | Buy |
20,940
+12,724
| +155% | +$3.33K | 0.15% | 136 |
|
|
2021
Q4 | $2.36K | Buy |
8,216
+8,212
| +205,300% | +$2.36K | 0.05% | 318 |
|
|
2021
Q3 | $605K | Hold |
4
| – | – | 0.28% | 68 |
|
|
2021
Q2 | $559K | Sell |
4
-2
| -33% | -$280K | 0.2% | 76 |
|
|
2021
Q1 | $2.62K | Sell |
6
-16
| -73% | -$6.97K | 0.05% | 220 |
|
|
2020
Q4 | $10K | Buy |
+22
| New | +$10K | 0.01% | 179 |
|
|
2020
Q2 | – | Sell |
-151
| Closed | -$73.9K | – | 692 |
|
|
2020
Q1 | $73.9K | Sell |
151
-103
| -41% | -$50.4K | 0.23% | 49 |
|
|
2019
Q4 | $375K | Sell |
254
-128
| -34% | -$189K | 0.26% | 36 |
|
|
2019
Q3 | $106K | Sell |
382
-85
| -18% | -$23.6K | 0.09% | 196 |
|
|
2019
Q2 | $146K | Sell |
467
-100
| -18% | -$31.3K | 0.12% | 184 |
|
|
2019
Q1 | $232K | Buy |
+567
| New | +$232K | 0.19% | 120 |
|
|
2018
Q3 | $226K | Buy |
672
+101
| +18% | +$34K | 0.24% | 96 |
|
|
2018
Q2 | $211K | Sell |
571
-143
| -20% | -$52.8K | 0.2% | 102 |
|
|
2018
Q1 | $211K | Buy |
+714
| New | +$211K | 0.22% | 84 |
|